STAT

JANUARY 10, 2023

Five studies co-authored by Tessier-Lavigne are now under the microscope for containing alleged altered images: a 1999 Cell study , a 2008 paper in the EMBO Journal, a 2003 Nature study, and two studies published in 2001 in Science.

328

328

STAT

DECEMBER 12, 2022

The deal is the largest pharma merger announced this year, and it represents the most that Amgen has spent on an acquisition since its $16 billion purchase of Immunex in 2001. Amgen said Monday it would purchase Horizon Pharmaceuticals for $27.8 Continue to STAT+ to read the full story…

Pharmaceutical Companies 222

Pharmaceutical Companies Pharmaceutical Companies 222

STAT

AUGUST 31, 2023

The retractions come the same day that Tessier-Lavigne’s resignation as Stanford president takes effect.

328

328

STAT

JANUARY 31, 2023

The program is widely considered a success and has worked well for many drugs, including the leukemia drug Gleevec , which the FDA approved in 2001 after a review period of just two-and-a-half months, based on study results that correctly predicted successful clinical outcomes. Continue to STAT+ to read the full story…

Drug Pricing 219

Drug Pricing 219

STAT

JULY 17, 2023

The study was shut down early — and a year later, prescriptions had plummeted to nearly half what they had been in 2001.  But in 2002, the therapy went into a free-fall when a landmark trial suggested treating menopause with estrogen and progesterone increased the risk of breast cancer and cardiovascular disease.

222

222

EMCrit Project

SEPTEMBER 28, 2023

Major interest in tight glycemic control in the ICU began in 2001 with an RCT by the same group of investigators, also […] EMCrit Project by Josh Farkas. background Today the Van de Bergh group in Belgium released a RCT investigating tight versus liberal glycemic control in the ICU.

118

118

STAT

APRIL 11, 2024

stood at 323 during the fourth quarter of last year — the highest figure reached since such data began being tracked in 2001 — underscoring growing concerns about patient harm across the country, STAT tells us. Unresolved The number of ongoing and active drug shortages in the U.S.

Chemotherapy 207

Chemotherapy Immunity Immunization 207

Outsourcing Pharma

JULY 26, 2023

Leslie Orne joined Trinity Life Sciences in 2001 and was recently appointed CEO and president of the fast-growing healthcare consultancy. She previously held the title of chief commercial officer (CCO) and president.

70

70

STAT

DECEMBER 12, 2022

The deal is the largest pharmaceutical merger announced this year, and it represents the most that Amgen has spent on an acquisition since its $16 billion purchase of Immunex in 2001. The The product is expected to generate $1.97 billion in 2022 and $2.26 billion in 2023, according to FactSet, an investment data firm.

221

221

Pharmaceutical Technology

JULY 10, 2023

The US FDA has granted orphan drug designation (ODD) for Ichnos Sciences’ ISB 2001 to treat patients with multiple myeloma.

52

52

NY Times

DECEMBER 2, 2021

In 2001, U.N. estimates suggested 150 million people would be infected with H.I.V. That preceded an ambitious global campaign to curb the virus. How well did it work?

Immunity 59

Immunity Immunization 59

Express Pharma

JANUARY 22, 2024

The drugmaker received funding to develop the RTS,S-based vaccine for young children in 2001, it said. The vaccine has been in the making for nearly 40 years. It was first created in 1987, according to GSK.

Vaccines 103

Vaccines 103

pharmaphorum

DECEMBER 1, 2022

Led by the MPE CEE Workgroup on Access, the report – Addressing access barriers to myeloma clinical trials in Central and Eastern Europe – evaluated the number of clinical trials held in CEE countries between 1 January 2001 and 28 September 2020. Approximately 50,000 people in Europe are diagnosed with myeloma each year.

72

72

FDA Law Blog: Biosimilars

MAY 3, 2023

Before joining HP&M in 2001, Mr. Houck conducted numerous scheduled cyclic and targeted inspections and investigations as a DEA Diversion Investigator in the field for ten years. Registrants are far from powerless when DEA investigators inspect their controlled substance operations.

Controlled Substances 52

Controlled Substances 52

RX Note

JUNE 13, 2023

External Links Clinical Inertia and Outpatient Medical Errors Clinical inertia, 2001 Clinical inertia is the enemy of therapeutic success in the management of diabetes and its complications: a narrative literature review, 2020

Clinic Management 52

Clinic Management Diabetes Communication 52

FDA Law Blog: Biosimilars

SEPTEMBER 12, 2023

In this webinar you’ll learn: How employees diverted controlled substances — their methods are constantly evolving What red flags were missed DEA inspection priorities Safeguards to minimize internal diversion Best practices for maximizing diversion detection Mr. Houck was a DEA Diversion Investigator for 15 years prior to joining HPM in 2001.

Controlled Substances 49

Controlled Substances Hospitals 49

PharmaShots

MAY 3, 2023

Additionally, high-throughput CRISPR editing is used by Artisan's SyionAI platform for novel drug discovery Ref: PR Newswire | Image: BrightPath Biotherapeutics Related News:- REGiMMUNE Entered into a License Agreement with San Fu Biotech to Develop and Commercialize RGI-2001 for the Prophylaxis of Acute Graft-Versus-Host Disease

40

40

Pharma Leaders

MAY 12, 2023

Founded in 2001 and headquartered in Guelph, Ontario, Canada, Nutrasource is a global contract research organisation (CRO) in the pharmaceutical and nutraceutical businesses. The company will initially buy a 60% interest in Nutrasource while having the right to pick the remaining 40% holding in 2026.

52

52

Pharmaceutical Business Review

MAY 12, 2023

Founded in 2001 and headquartered in Guelph, Ontario, Canada, Nutrasource is a global contract research organisation (CRO) in the pharmaceutical and nutraceutical businesses. The company will initially buy a 60% interest in Nutrasource while having the right to pick the remaining 40% holding in 2026.

52

52

Pharmacy Joe

JANUARY 24, 2024

For example, if the new article is about glucose control in the ICU, you can be sure that the letter to the editor will mention other landmark trials such as 2001 article by Van Den Berghe and NICE-SUGAR.

Inpatient 98

Inpatient Hospitals 98

FDA Law Blog: Biosimilars

SEPTEMBER 26, 2023

In this webinar you’ll learn: How employees diverted controlled substances — their methods are constantly evolving What red flags were missed DEA inspection priorities Safeguards to minimize internal diversion Best practices for maximizing diversion detection Mr. Houck was a DEA Diversion Investigator for 15 years prior to joining HPM in 2001.

Controlled Substances 45

Controlled Substances Hospitals 45

pharmaphorum

JANUARY 6, 2022

H3B-8800 – now renamed RVT-2001 – will be taken in a slightly different direction by Roivant, which said it plans to develop it as a therapy for transfusion-dependent anaemia in patients with lower-risk MDS, according to the company.

Compounding 52

Compounding Drug Development 52

FDA Law Blog: Biosimilars

MAY 22, 2023

Before joining HP&M in 2001, Mr. Houck conducted numerous scheduled cyclic and targeted inspections and investigations as a DEA Diversion Investigator in the field for ten years. Registrants are far from powerless when DEA investigators inspect their controlled substance operations.

Controlled Substances 40

Controlled Substances 40

RX Note

JUNE 11, 2023

External Links UpToDate - Paronychia Acute paronychia: comparative treatment with topical antibiotic alone or in combination with corticosteroid, 2001 Acute felon and paronychia: Antibiotics not necessary after surgical treatment. Refractory chronic paronychia - consider surgical intervention.

Diabetes 52

Diabetes Community Pharmacies 52

European Pharmaceutical Review

JANUARY 25, 2024

Proposal for a Directive of the European Parliament and of the Council on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC.” References European Commission, (26 April 2023). Article 63 EMA (29 January 2020). Article 63 Euractiv (26 September 2023).

Packaging 80

Packaging Documentation Communication Pharmaceutical Companies 80

RX Note

JULY 16, 2023

External Links A randomized, controlled clinical trial of four anti-dandruff shampoos, 1981 Effect of ketoconazole 1% and 2% shampoos on severe dandruff and seborrhoeic dermatitis: clinical, squamometric and mycological assessments, 2001 A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic (..)

Community Pharmacies 52

Community Pharmacies 52

Pharmacy Is Right For Me

OCTOBER 21, 2022

I worked in Dallas from 95-2001, then moved to NYC, then years later went to the University of Colorado for the NTPD program and received the PharmD. What makes your career path unique?  My focus in Pharmacy School at OU was Nuclear Medicine. There was a fully operational Nuclear Pharmacy on campus, and I took all the courses.

Hospitals 130

Hospitals Labelling Vaccines Drug Development 130

Pharmaceutical Technology

JULY 18, 2022

The latest contract comes after previous agreements between the parties for seasonal influenza and pandemic vaccines dating back to 2001. The company intends to supply both vaccines from its 230,000ft² Sainte-Foy facility in Quebec. .

Vaccines 64

Vaccines Immunity Immunization 64

European Pharmaceutical Review

JUNE 24, 2022

Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. One of the key priorities of the EU’s strategy is to encourage innovation to solve unmet medical needs. Brussels; 2020.

Compounding 97

Compounding Drug Development Drug Pricing Dosage 97

pharmaphorum

NOVEMBER 18, 2020

Since being founded in 2001, Envision has delivered strong year-on-year organic growth and established leadership in medical affairs strategy, medical communications, and enterprise-wide Envision technology.

Communication 72

Communication Pharmaceutical Companies Pharmaceutical Companies 72

RX Note

APRIL 2, 2024

External Links ACR Manual on Contrast Media, 2023 Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material, 1987 Prevention of generalized reactions to contrast media: a consensus report and guidelines, 2001 Allergic-like breakthrough reactions to gadolinium contrast agents after corticosteroid and antihistamine premedication, (..)

52

52

pharmaphorum

JANUARY 13, 2021

W20 was founded in 2001 by Jim Weiss and now employs 1,500 people, using analytics and technology to build insights for clients in the life sciences industry. W20 has been on the acquisition trail since it announced a partnership with New Mountain Capital in 2019. The post W20 acquires data technology firms Swoop and IPM.ai

52

52

RX Note

MARCH 5, 2024

External Links Acupressure and motion sickness, 1990 A comparison of the efficacy of cinnarizine with scopolamine in the treatment of seasickness, 1994 Acupressure relieves the symptoms of motion sickness and reduces abnormal gastric activity, 2001 Zingiberis rhizoma: a comprehensive review on the ginger effect and efficacy profiles, 2005 Scopolamine (..)

40

40

RX Note

DECEMBER 10, 2023

External Links Oral rehydration therapy plus loperamide versus loperamide alone in the treatment of traveler's diarrhea, 1999 Reduced osmolarity oral rehydration solution for treating dehydration due to diarrhoea in children: systematic review, 2001 Management of Acute Diarrhoea in Children, 2011

Community Pharmacies 52

Community Pharmacies 52

European Pharmaceutical Review

APRIL 13, 2023

For example, the relaxed attitude towards cannabis in the Netherlands is well-known and Portugal has decriminalised the possession and consumption of all illicit substances since 2001.

Biosimilars 113

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 113

PharmaShots

APRIL 7, 2023

TG Therapeutics Receives EMA’s CHMP Positive Opinion of Briumvi (ublituximab-xiiy) for the Treatment of Relapsing Forms of Multiple Sclerosis Date: Apr 3, 2023 | Tags: TG Therapeutics, Briumvi, Ublituximab-xiiy, Multiple Sclerosis, Regulatory, EMA, CHMP BMS Receives EMA’s CHMP Positive Opinion of Breyanzi (lisocabtagene maraleucel) for (..)

Biosimilars 53

Biosimilars Immunity Immunization 53

pharmaphorum

JUNE 8, 2022

Starting out as a Medical Communications agency in 2001, the company has developed into a global, full-service commercialization and healthcare advisory partner with services focused on evidence generation and access strategy, medical communications, scientific marketing, and strategic healthcare consulting. .

Communication 52

Communication 52